Who invested in Cerevast Therapeutics?
Cerevast Therapeutics's investors include UT Horizon Fund.
United States · Series C startup
7 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 7 rounds since 2010, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $11M sold, first sale Dec 2014
No investor was named in the report.
From a historical funding recordSEC filing: $1.8M sold, first sale Nov 2013
No investor was named in the report.
Reported by sec.govSEC filing: $1.8M sold, first sale Nov 2013
No investor was named in the report.
Reported by sec.govSEC filing: $1.5M sold, first sale Apr 2013
No investor was named in the report.
Reported by sec.govSEC filing: $215K sold, first sale Sept 2011
No investor was named in the report.
Reported by sec.govSEC filing: $2.0M sold, first sale Dec 2009
Cerevast Therapeutics's investors include UT Horizon Fund.
Cerevast Therapeutics has raised $25M across 7 rounds since 2010.
Cerevast Therapeutics's most recent round was a Series C of $11M in Mar 2015.
Its most recent round, $11M in Mar 2015, is also its largest on record.
Cerevast Therapeutics's first round on record, in Dec 2011, was backed by UT Horizon Fund.
Cerevast Therapeutics's latest named round is a Series C, in Mar 2015.
Cerevast Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.